COMMUNIQUÉS West-GlobeNewswire

Preliminary Phase 1b/2 Data for REC-4881 in Familial Adenomatous Polyposis (FAP) Demonstrates Reduced Polyp Burden
04/05/2025
In the Phase 2 open-label study, REC-4881 (4 mg QD) led to a median 43% reduction (n=6 patients) in polyp burden at the Week 13 assessment at time of data cutoff. Five of six patients (83%) experienced reductions in [...]
Best Supplements For Muscle Growth: Top Legal Bodybuilding Supplements & Anabolic Steroids For Bulking, Cutting & Strength
03/05/2025
Backed by Wolfson Brands (UK) Limited, Discover the best supplements for muscle growth, including top legal alternatives to anabolic steroids in 2025. Explore expert-recommended products for bulking, cutting, and [...]
Mitolyn Reviews 2025: Exploring Faux Reviews, Consumer Complaints, & How to Buy Real Mitolyn Purple Peel Exploit!
03/05/2025
Seattle, May 03, 2025 (GLOBE NEWSWIRE) -- As more individuals become health-conscious, and as stimulants continue to be avoided due to health concerns, it should come as no surprise that more people are searching out [...]
Buy Ibutamoren MK 677 SARMS for Sale Online: MK-677 Before After Results - Where to Order Legal Ibutamoren SARM OTC, Buyers Guide from CrazyBulk
03/05/2025
New York City, May 03, 2025 (GLOBE NEWSWIRE) -- If you’re serious about packing on size, crushing PRs, and building a physique that commands attention, chances are you’ve heard of Ibutamoren MK-677. Legal Ibutamoren MK [...]
Bioma Review 2025: Revolutionizing Gut Health or Just Another Fad? Honest Analysis Inside By Bioma Probiotic!
03/05/2025
Gut transformation through Bioma a perfectly blended combination of probiotics prebiotics and postbiotics New York City, May 03, 2025 (GLOBE NEWSWIRE) -- The scientific discussion about gut health has become the [...]
IBA launches QUASAR® GRID3D Advantage Image Distortion Analysis System
03/05/2025
New standard in the Quality Assurance of image distortion for MR guided radiation therapy and MR simulation in planning Louvain-la-Neuve, Belgium, 3 May 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world [...]
IBA lance QUASAR® GRID3D Advantage, un système d'analyse de distorsion d'image
03/05/2025
Nouvelle norme pour l'assurance qualité de la distorsion de l'image pour la radiothérapie guidée par résonnance magnétique et la simulation de plan de traitement Louvain-la-Neuve, Belgique, le 3 mai 2025 – IBA (Ion Beam [...]
Endogenex Highlights 48-Week REGENT-1 Clinical Study Results at Digestive Disease Week 2025
03/05/2025
Novel Endoscopic Procedure Demonstrates Substantial and Durable Reduction in Insulin Resistance and Improvement in Beta Cell Function for People with Type 2 Diabetes MINNEAPOLIS, May 03, 2025 (GLOBE NEWSWIRE) -- [...]
SlimJaro Canada, Australia, UK, Reviews, Official Website, Discount Code, Trustpilot Complaints
03/05/2025
Lakeland, FL, May 03, 2025 (GLOBE NEWSWIRE) -- SlimJaro Canada: The Revolutionary Fat-Burning Formula Redefining Weight Management: Imagine a world where shedding stubborn fat doesn’t involve grueling diets, endless gym [...]
Javy Protein Coffee Under Review: Best Protein Coffee with Premium Ingredients by Javy Protein Coffee
03/05/2025
Discover why Javy Protein Coffee is the best protein coffee for energy, recovery, and flavor. Fast, convenient, zero sugar—perfect for fitness lovers and busy mornings. Summerville, South Carolina, May 03, 2025 (GLOBE [...]
Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08
03/05/2025
PURCHASE, N.Y., May 02, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued inducement awards to five new employees. Effective April 30, 2025, in [...]
INP and Fight For Life Club Foundation Make History: Two Pediatric Living Donor Liver Transplants in One Week
03/05/2025
Dallas, Texas, May 02, 2025 (GLOBE NEWSWIRE) -- In a historic medical achievement, the National Institute of Pediatrics (INP), in collaboration with the Fight For Life Club Foundation , has successfully performed two [...]
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/05/2025
BOSTON, May 02, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous [...]
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/05/2025
VANCOUVER, British Columbia and BOSTON, May 02, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering [...]
Result of General Meeting
02/05/2025
May 2, 2025 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Result of General Meeting Biodexa Pharmaceuticals PLC, (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative [...]
Xilio Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
02/05/2025
WALTHAM, Mass., May 02, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with [...]
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/05/2025
SAN FRANCISCO, May 02, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and [...]
New Data at DDW 2025 Further Demonstrates the TissueCypher® Test's Ability to Identify Patients at Increased Risk for Developing Esophageal Cancer
02/05/2025
Additionally, an expert physician panel convened by EndoscopyNow will host a product theater on Sunday, May 4, at 2:45 p.m. Pacific Time, titled, “The Time is Now: A Clinical Practice Model to Help Prevent Progression [...]
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
02/05/2025
SOUTH SAN FRANCISCO Calif. and SAN DIEGO, May 02, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of [...]

Pages